Clinical Trial Update: NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer [NA]

View source ↗

Summary

A clinical trial update for NOAC9 investigating circulating tumor DNA-guided follow-up in anal cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• NOAC9

Snippet

Sponsor: Aarhus University Hospital | Conditions: Anal Cancer | NA | Status: RECRUITING